Premium
Morgan Stanley Private Equity and Indian healthcare-focused private equity firm InvAscent are in an advanced stage of talks to jointly pick up a majority stake in a company that primarily makes sterile injectables for large drugmakers, two people aware of the development told VCCircle. The PE firms are in the final ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
